Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Rutgers University
- The University of Arizona
- Institute for bioengineering of Catalonia, IBEC
- Stanford University
- University of North Carolina at Chapel Hill
- Northeastern University
- Texas A&M University
- University of Arkansas
- University of Minnesota
- University of Washington
- ETH Zürich
- Institute of Medical Biology Chinese Academy of Medical Sciences (IMBCAMS)
- NEW YORK UNIVERSITY ABU DHABI
- Nencki Institute of Experimental Biology
- Pennsylvania State University
- Polymer Institute of the Slovak Academy of Sciences
- SUNY University at Buffalo
- Universidade de Coimbra
- University of Colorado
- University of Kansas Medical Center
- University of Nebraska Medical Center
- University of South Carolina
- Università degli Studi di MESSINA
- Washington University in St. Louis
- Łukasiewicz Research Network - Krakow Institute of Technology
- 15 more »
- « less
-
Field
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 9 days ago
of Pharmacoengineering and Molecular Pharmaceutics (DPMP) is engaged in research and education in drug delivery options to optimize the therapeutic efficacy of pharmacologically and immunologically active agents. It is a
-
vaccines. The laboratory has several ongoing clinical trials that involve many different platforms for the delivery and clinical benefit of personalized cancer vaccines. The ideal candidate for this role
-
of Professor Mazin Magzoub, will focus on developing protein- and synthetic small molecule-based inhibitors, and novel drug delivery platforms, for pathogenic protein self-assembly associated with Alzheimer’s
-
CENTRO2030-FEDER-02360600, title ImpulseN2BD - Nose-to-brain drugs for the treatment of depression: boosting translational potential The call is governed by this Notice of Opening, the University of Coimbra
-
Website: https://healthpolicy.fsi.stanford.edu/(link is external) How to Submit Application Materials: Please submit the required application materials to Dr. Goldhaber-Fiebert ([email protected](link
-
of innovative forms of brain delivery and targeting of selected drugs - n. 1 post-doc assignment in GSD 03/CHEM-07 SSD CHEM-07/A for the research program “OS4. - Development of a pharmaceutical development
-
to investigate cancer biology, therapeutic response, immunotherapy, and drug delivery in small-animal models. Design and optimize MRI protocols for longitudinal preclinical studies. Perform quantitative image
-
similar. Multidisciplinary qualifications and/or knowledge of nanoparticles and drug delivery systems (specific knowledge of enzyme catalysis and nanomotors will be a plus). Competencies and skills
-
University of North Carolina at Chapel Hill | Chapel Hill, North Carolina | United States | 17 days ago
proficiency in scientific/manuscript writing, grant writing, poster and oral presentations. - Preferred candidates will have strong publication record. - Postdoctoral training with focus areas in: Drug Delivery
-
) Foundation Research Starter Grant in Drug Delivery, and several pilot and seed grants from the State of Arizona, University of Arizona Comprehensive Cancer Center, and The Southwest Environmental Health